{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:58:20Z","timestamp":1780383500067,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"James and Emmeline Ferguson Research Fellowship Trust"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cellimm.2020.104197","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T21:24:05Z","timestamp":1597958645000},"page":"104197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Interferon-gamma increases monocyte PD-L1 but does not diminish T-cell activation"],"prefix":"10.1016","volume":"357","author":[{"given":"Norman J.","family":"Galbraith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel P.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Campbell","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Galandiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Hiram C.","family":"Polk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2020.104197_b0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccc.2016.08.006","article-title":"Postinjury inflammation and organ dysfunction","volume":"33","author":"Sauaia","year":"2017","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.cellimm.2020.104197_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/CCM.0000000000000723","article-title":"Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study","volume":"43","author":"Levy","year":"2015","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cellimm.2020.104197_b0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.surg.2018.04.011","article-title":"Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery","volume":"164","author":"Efron","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.cellimm.2020.104197_b0020","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/cc7914","article-title":"Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a cohort study","volume":"13","author":"Kirchhoff","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.cellimm.2020.104197_b0025","doi-asserted-by":"crossref","first-page":"R208","DOI":"10.1186\/cc9331","article-title":"Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma","volume":"14","author":"Cheron","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.cellimm.2020.104197_b0030","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cellimm.2020.104197_b0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fimmu.2018.00595","article-title":"Innate immunity in the persistent inflammation, immunosuppression, and catabolism syndrome and its implications for therapy","volume":"9","author":"Horiguchi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2020.104197_b0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","article-title":"Endotoxin tolerance: new mechanisms, molecules and clinical significance","volume":"30","author":"Biswas","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2020.104197_b0045","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment","volume":"3","author":"Docke","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2020.104197_b0050","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/00003246-200207000-00015","article-title":"Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma","volume":"30","author":"Nakos","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cellimm.2020.104197_b0055","doi-asserted-by":"crossref","unstructured":"D.J. Dries, G.J. Jurkovich, R.V. Maier, T.P. Clemmer, S.N. Struve, J.A. Weigelt, G.G. Stanford, D.L. Herr, H.R. Champion, F.R. Lewis, et al., Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial, Arch. Surg. 129 (1994) 1031\u20131041; discussion 1042.","DOI":"10.1001\/archsurg.1994.01420340045008"},{"key":"10.1016\/j.cellimm.2020.104197_b0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0002-9610(92)90099-D","article-title":"A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients","volume":"163","author":"Polk","year":"1992","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.cellimm.2020.104197_b0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00003246-199803000-00010","article-title":"Interferon-gamma in the prevention of severe burn-related infections: a European phase III multicenter trial. The Severe Burns Study Group","volume":"26","author":"Wasserman","year":"1998","journal-title":"Crit. Care Medi."},{"key":"10.1016\/j.cellimm.2020.104197_b0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/sur.2016.014","article-title":"Past, present, and future of augmentation of monocyte function in the surgical patient","volume":"17","author":"Galbraith","year":"2016","journal-title":"Surg. Infect."},{"key":"10.1016\/j.cellimm.2020.104197_b0075","doi-asserted-by":"crossref","unstructured":"W. Xiao, M.N. Mindrinos, J. Seok, J. Cuschieri, A.G. Cuenca, H. Gao, D.L. Hayden, L. Hennessy, E.E. Moore, J.P. Minei, P.E. Bankey, J.L. Johnson, J. Sperry, A.B. Nathens, T.R. Billiar, M.A. West, B.H. Brownstein, P.H. Mason, H.V. Baker, C.C. Finnerty, M.G. Jeschke, M.C. Lopez, M.B. Klein, R.L. Gamelli, N.S. Gibran, B. Arnoldo, W. Xu, Y. Zhang, S.E. Calvano, G.P. McDonald-Smith, D.A. Schoenfeld, J.D. Storey, J.P. Cobb, H.S. Warren, L.L. Moldawer, D.N. Herndon, S.F. Lowry, R.V. Maier, R.W. Davis, R.G. Tompkins, Inflammation, P. Host Response to Injury Large-Scale Collaborative Research, A genomic storm in critically injured humans, J. Exp. Med. 208 (2011) 2581\u20132590.","DOI":"10.1084\/jem.20111354"},{"key":"10.1016\/j.cellimm.2020.104197_b0080","doi-asserted-by":"crossref","unstructured":"T. Murphy, H. Paterson, S. Rogers, J.A. Mannick, J.A. Lederer, Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients, Ann. Surg. 238 (2003) 401\u2013410; discussion 410\u2013401.","DOI":"10.1097\/01.sla.0000086661.45300.14"},{"key":"10.1016\/j.cellimm.2020.104197_b0085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/107999003321532484","article-title":"Effects of perioperative recombinant human IFN-gamma (rHuIFN-gamma) application in vivo on T cell response","volume":"23","author":"Licht","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cellimm.2020.104197_b0090","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0607028103","article-title":"Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways","volume":"103","author":"Laudanski","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2020.104197_b0095","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/cc10059","article-title":"Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients","volume":"15","author":"Zhang","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.cellimm.2020.104197_b0100","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.surg.2018.05.042","article-title":"Temporal expression of circulating miRNA after severe injury","volume":"164","author":"Galbraith","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.cellimm.2020.104197_b0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cei.12995","article-title":"Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation","volume":"190","author":"Li","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2020.104197_b0110","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1189\/jlb.4HI0616-255R","article-title":"Frontline science: defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1","volume":"100","author":"Patera","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2020.104197_b0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13054-016-1301-x","article-title":"Monocyte programmed death ligand-1 expression after 3\u20134 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study","volume":"20","author":"Shao","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.cellimm.2020.104197_b0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/SHK.0b013e31825de6a3","article-title":"Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient","volume":"38","author":"Monaghan","year":"2012","journal-title":"Shock"},{"key":"10.1016\/j.cellimm.2020.104197_b0125","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1073\/pnas.0809422106","article-title":"PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis","volume":"106","author":"Huang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2020.104197_b0130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMcibr1404664","article-title":"Parallels between cancer and infectious disease","volume":"371","author":"Hotchkiss","year":"2014","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.cellimm.2020.104197_b0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13054-016-1370-x","article-title":"Sepsis in PD-1 light","volume":"20","author":"Monneret","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.cellimm.2020.104197_b0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","article-title":"Persistent lymphopenia after diagnosis of sepsis predicts mortality","volume":"42","author":"Drewry","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.cellimm.2020.104197_b0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/JLB.5HI0917-360R","article-title":"Anti-PD-L1 protects against infection with common bacterial pathogens after burn injury","volume":"103","author":"Patil","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2020.104197_b0150","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/cc9354","article-title":"PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction","volume":"14","author":"Zhang","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.cellimm.2020.104197_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.0110037","article-title":"Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis","volume":"88","author":"Brahmamdam","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2020.104197_b0160","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/cc13176","article-title":"Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis","volume":"18","author":"Chang","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.cellimm.2020.104197_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/JLB.2MIR0917-377R","article-title":"A novel role for coinhibitory receptors\/checkpoint proteins in the immunopathology of sepsis","author":"Fallon","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2020.104197_b0170","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2020.104197_b0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0162-3109(00)00195-8","article-title":"Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells","volume":"48","author":"Heinzelmann","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.cellimm.2020.104197_b0180","article-title":"The effect of IkappaK-16 on lipopolysaccharide-induced impaired monocytes","author":"Galbraith","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2020.104197_b0185","doi-asserted-by":"crossref","first-page":"R252","DOI":"10.1186\/cc10513","article-title":"mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance","volume":"15","author":"Turrel-Davin","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.cellimm.2020.104197_b0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ni.3398","article-title":"Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis","volume":"17","author":"Cheng","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2020.104197_b0195","doi-asserted-by":"crossref","unstructured":"D.H. Livingston, P.A. Loder, U.E. Gibson, H.C. Polk, Interferon gamma administration increases monocyte HLA-DR antigen expression but not endogenous interferon production, Arch. Surg. 129 (1994).","DOI":"10.1001\/archsurg.1994.01420260068009"},{"key":"10.1016\/j.cellimm.2020.104197_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072249","article-title":"IFN-gamma-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1","volume":"8","author":"de Kleijn","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2020.104197_b0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2249.2001.01628.x","article-title":"Interferon-gamma administration after abdominal surgery rescues antigen-specific helper T cell immune reactivity","volume":"125","author":"Rentenaar","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2020.104197_b0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/srep00295","article-title":"TNF-alpha and TGF-beta counter-regulate PD-L1 expression on monocytes in systemic lupus erythematosus","volume":"2","author":"Ou","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2020.104197_b0215","doi-asserted-by":"crossref","first-page":"20683","DOI":"10.1074\/jbc.M117.809053","article-title":"MicroRNA-155 induction via TNF-alpha and IFN-gamma suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells","volume":"292","author":"Yee","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2020.104197_b0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/infdis\/jix279","article-title":"PD-L1 overexpression during endotoxin tolerance impairs the adaptive immune response in septic patients via HIF1\u03b1","volume":"217","author":"Avenda\u00f1o-Ortiz","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2020.104197_b0225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/08820139.2017.1407786","article-title":"Ex vivo stimulation of lymphocytes with IL-10 mimics sepsis-induced intrinsic T-cell alterations","volume":"47","author":"Poujol","year":"2018","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.cellimm.2020.104197_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041052","article-title":"Regulatory T cells modulate CD4 proliferation after severe trauma via IL-10","volume":"9","author":"Sturm","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.cellimm.2020.104197_b0235","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1186\/s12879-019-4526-x","article-title":"Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series","volume":"19","author":"Payen","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cellimm.2020.104197_b0240","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.cellimm.2020.104197_b0245","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/CCM.0000000000003685","article-title":"Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559)","volume":"47","author":"Hotchkiss","year":"2019","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cellimm.2020.104197_b0250","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/CCM.0000000000000222","article-title":"A better understanding of why murine models of trauma do not recapitulate the human syndrome","volume":"42","author":"Gentile","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cellimm.2020.104197_b0255","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/cc9283","article-title":"A novel model of common Toll-like receptor 4- and injury-induced transcriptional themes in human leukocytes","volume":"14","author":"Haimovich","year":"2010","journal-title":"Crit. Care"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874920303579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:23:26Z","timestamp":1762107806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874920303579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":51,"alternative-id":["S0008874920303579"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104197","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-gamma increases monocyte PD-L1 but does not diminish T-cell activation","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2020.104197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104197"}}